Our group recently identified USP7 as another regulator of ERβ stability in osimertinib-resistant NSCLC cells [6], suggesting coordinated control by both E3 ligases (e.g., SCF complex components or VHL) and deubiquitinases (e.g., USP family members) in LUAD. Here, VHL is linked to non-small cell lung carcinoma.